Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02682316
Other study ID # 15-309
Secondary ID
Status Completed
Phase Phase 3
First received
Last updated
Start date February 2016
Est. completion date January 25, 2024

Study information

Verified date January 2024
Source Memorial Sloan Kettering Cancer Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to compare any good and bad effects of using the Prevena Incision Management System to using the usual standard dry gauze approach. The Prevena Incision Management System is a type of Negative Pressure Wound Therapy (NPWT). NPWT is a portable vacuum device made of a sponge-like foam that is applied over your incision to help draw fluid and debris out after surgery.


Recruitment information / eligibility

Status Completed
Enrollment 577
Est. completion date January 25, 2024
Est. primary completion date January 25, 2024
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: Criteria for Eligibility Prior to Surgery: - Women of any BMI undergoing a laparotomy procedure for a presumed gynecologic malignancy, or morbidly obese (BMI = 40) women undergoing a laparotomy for any indication - or women who are morbidly obese (BMI>40) undergoing laparotomy for any indication - Age = 18 Criteria for Eligibility During Surgery: - Women of any BMI undergoing a laparotomy procedure for a presumed gynecologic malignancy, or morbidly obese (BMI = 40) women undergoing a laparotomy for any indication - or women who are morbidly obese (BMI>40) undergoing laparotomy for any indication - Age = 18 Exclusion Criteria: Exclusion prior to Surgery: - Women undergoing panniculectomy at the time of laparotomy - Women with sensitivity to silver Exclusion during Surgery: - Women with laparotomy incisions left open due to case classification as "contaminated" or "dirty" - Women with laparotomy incisions unable to be closed primarily due to tissue or fascial damage

Study Design


Related Conditions & MeSH terms


Intervention

Other:
dry gauze

Device:
The Prevena Incision Management System


Locations

Country Name City State
United States Lehigh Valley Health Network Allentown Pennsylvania
United States Memorial Sloan Kettering Basking Ridge (Consent and Follow-Up only) Basking Ridge New Jersey
United States Memorial Sloan Kettering Commack (Consent and Follow-Up only) Commack New York
United States Memorial Sloan Kettering Westchester (Consent and Follow-Up only) Harrison New York
United States Hartford Healthcare Cancer Institute @ Hartford Hospital Hartford Connecticut
United States Memorial Sloan Kettering Monmouth (Consent and Follow-Up only) Middletown New Jersey
United States Memorial Sloan Kettering Bergen (Consent and Follow-Up only) Montvale New Jersey
United States Memorial Sloan Kettering Cancer Center New York New York
United States Memorial Sloan Kettering Rockville (Consent and Follow-Up only) Rockville Centre New York
United States Memorial Sloan Kettering Nassau (Consent and Follow-Up only) Uniondale New York

Sponsors (3)

Lead Sponsor Collaborator
Memorial Sloan Kettering Cancer Center 3M, Miami Cancer Institute

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary number of post-op wound complications Incidence of inpatient post-operative wound complications will be documented through the use of an inpatient data collection sheet. Incidence of outpatient post-operative wound complication will be documented through the use of an outpatient data collection sheet that will be completed by a provider at the time of the routine post-operative follow-up visit, which will occur at 30 days +/- 5 days after the day of surgery as well as through ongoing documentation of events as elicited through the institution's standard reporting system to collect information on enrolled patients. 30 days +/- 5 days after surgery
See also
  Status Clinical Trial Phase
Recruiting NCT02892435 - Prevena™ Incision Management System vs Conventional Management for Wound Healing Phase 2
Recruiting NCT04618406 - The Effect of Negative Pressure Wound Therapy on Wound Healing in Major Amputations of the Lower Limb N/A
Not yet recruiting NCT01603901 - Regulated Negative Pressure-Assisted Wound Therapy Device N/A
Terminated NCT04026334 - Evaluation of V.A.C. VERAFLO CLEANSE CHOICE™ Dressing Using Normal Saline to Promote Increased Healthy Wound Bed Tissue N/A
Recruiting NCT05716503 - Comparison Between Negative Pressure Wound Therapy and Conventional Wound Dressings Before and After Split-Thickness Skin Grafting in Diabetic Foot Wounds N/A
Recruiting NCT02901613 - Prophylactic Post-Cesarean Incisional Negative-pressure Wound Therapy in Morbidly Obese Patients N/A
Completed NCT02526342 - Impact of Negative Pressure Wound Therapy on Free Muscle Flaps N/A
Withdrawn NCT03566641 - Negative Pressure Wound Therapy vs Standard Care Dressing N/A